{"cursor":"9768","size":15,"audio":[],"currentlang":"en","article":"{{Drugbox\n| Verifiedfields = changed Watchedfields = changed verifiedrevid = 477241639\n| IUPAC_name = 2-Amino-N,Nâ€²- bis[(6S,9R,10S,13R,18aS)-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,11,14-\n| pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-\n| 10-yl]-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide image = Actinomycin\n| D.png drug_name = Actinomycin D\n\n\n| tradename = Cosmegen Drugs.com = MedlinePlus = a682224 pregnancy_category = D\n| legal_status = Rx-only routes_of_administration = IV\n\n\n| bioavailability = protein_bound = 5% metabolism = elimination_half-life =\n| 36 hours\n\n\n| CASNo_Ref = CAS_number_Ref = CAS_number = 50-76-0 ATC_prefix = L01 ATC_suffix\n| = DA01 ATC_supplemental = PubChem = 2019 DrugBank_Ref = DrugBank = DB00970\n| ChemSpiderID_Ref = ChemSpiderID = 10482167 NIAID_ChemDB = 009885 UNII_Ref =\n| UNII = 1CC1JFE158 KEGG_Ref = KEGG = C06770 ChEBI_Ref = ChEBI = 27666\n| ChEMBL_Ref = ChEMBL = 1554\n\n\n| C=62 | H=86 | N=12 | O=16 molecular_weight = 1255.42 g/mol InChI = 1/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-\n| 38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-\n| 46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-\n| 62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-\n| 74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-\n| 20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-\n| ,43-,44+,45+,48+,49+/m1/s1 InChIKey = RJURFGZVJUQBHK-IIXSONLDBN StdInChI_Ref =\n| StdInChI = 1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-\n| 38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-\n| 46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-\n| 62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-\n| 74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-\n| 20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-\n| ,43-,44+,45+,48+,49+/m1/s1 StdInChIKey_Ref = StdInChIKey = RJURFGZVJUQBHK-IIXSONLDSA-\n| N synonyms = 2-Amino- 4,6-dimethyl- 3-oxo- 3H-phenoxazine- 1,9-\n| dicarboxylic acid bis- [(5,12-diisopropyl- 9,13,16-trimethyl- 4,7,11,14,17-pentaoxo-\n| hexadecahydro- 10-oxa- 3a,6,13,16-tetraaza- cyclopentacyclohexadecen- 8-yl)-\n| amide]\n}}\n\n'Actinomycin D' (also known generically as 'Actinomycin' or 'Dactinomycin'), is\nthe most significant member of 'actinomycines', which are a class of\npolypeptide antibiotics isolated from soil bacteria of the genus\n[[Streptomyces]]. As one of the older chemotherapy drugs, it\nhas been used for many years.\n","linknr":-1,"url":"actinomycin","recorded":1376427580,"links":[],"instances":["medical","genetics"],"pdf":[],"categories":["Polypeptide antibiotics","DNA replication inhibitors","Depsipeptides","Cyclic peptides","Chemical compounds found in Streptomyces species","IARC Group 3 carcinogens"],"headings":["History","Mechanism","Clinical use","Side effects","Research use","References","External links"],"image":[],"tags":[["transcription","genetics"],["fatigue","medical"]],"members":["fatigue","transcription"],"related":["Intravenous_therapy","Polypeptide_antibiotics","Bacteria","Chemotherapy","Antibiotic","Cancer","Selman_Waksman","Food_and_Drug_Administration","Merck_Sharp_and_Dohme","Cell_biology","Transcription_(genetics)","DNA","RNA","RNA_polymerase","Gestational_trophoblastic_neoplasia","Wilms'_tumor","Rhabdomyosarcoma","Ewing's_sarcoma","Hydatidiform_mole","Chemotherapy_regimens","Vincristine","Cyclophosphamide","Radiosensitizer","Radiotherapy","Radiosensitivity","Tumor_cell","Adverse_drug_reaction","Bone_marrow_suppression","Fatigue_(medical)","Hair_loss","Mouth_ulcer","Loss_of_appetite","Diarrhea","Vesicant","DNA_replication","Hydroxyurea","Fluorescence","7-aminoactinomycin_D","Microscopy","Flow_cytometry"]}